Across TCGA pan-cancer cohorts, LINC01789 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01789’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01789 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01789 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

KIRC, THCA, and KICH are the cancer types where LINC01789 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01789 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+2.704	<.001	12	view →
THCA	All	IV	−2.780	<.001	9	view →
KICH	All	II,III,IV	−0.561	<.001	7	view →
LIHC	All	All	+0.007	.007	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC01789 RNA expression & survival · all LINC01789 data types